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Purpose of the study
HIV-patients often develop long-term pro-atherogenic
metabolic alterations. HDL-cholesterol (C) concentration
is known to be decreased in HIV-infected patients. Lipo-
protein metabolism changes occurring as host response to
infection include an antioxidant effect that is part of the
defense system. Paraoxonase (PON) are HDL-associated
enzymes that, due to their antioxidant properties, have
been considered the main factor responsible for the HDL
anti-atherogenic role. Higher HDL concentrations have
been associated with a better disease course in HIV
patients undergoing antiretroviral treatment. The aim of
this study was to determine relationship between HIV-
infection in treatment-naïve patients and activity of PON-
1 and lipoprotein concentrations.
Methods
This is an observational prospective study in HIV-infected
treatment-naïve patients, without treatment criteria, and
without viral hepatitis co-infection. After informed con-
sent, demographic characteristics and blood samples were
collected to assess CD4+ lymphocyte, viral load, total-C,
HDL-C, LDL-C, triglycerides and PON-1 activity. PON-1
activity was assessed by quantification of nitrophenol for-
mation by spectrophotometry and was expressed as U/L.
Chi-square test and Student's t-test were used to compare,
respectively, categorical and continuous variables. Spear-
man's test was used to analyze the correlation between
PON-1 activity and HDL-C, LDL-C, total-C and CD4+
count.
Summary of results
29 patients: male 18 (62%); female 11 (38%); mean age
38.36 ± 12.02 years; mean CD4+ count 501 ± 233,75
cells/μL; mean VL 3.99 ± 1.01 log10 copies/mL. Mean
total-C: 177.69 ± 38.45 mg/dL; HDL-C: 51.50 ± 20.321
mg/dL; LDL-C: 113.27 ± 29.36 mg/dL; triglycerides
106.72 ± 113.91 mg/dL; PON-1 activity: 69.26 ± 20.50 U/
L. PON-1 activity was significantly higher in patients with
>350 cells/μL (p = 0.008). A significant inverse relation
was observed between PON-1 activity and LDL-C (p =
0.03; r: 0.69).
Conclusion
According to our results, HIV-infected patients with CD4+
lymphocyte >350 cells/μL revealed greater PON-1 activity,
presumably associated with an antioxidant effect, less oxi-
dative stress and less metabolic disturbance. There was no
correlation with total-C, HDL-C and viral load. A possible
inverse correlation was found with LDL-C levels.
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